维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Lübbert"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Antibiotic treatment of enterococcal infections in gastroenterology with daptomycin-first experiences from the EU-CORE registry study(European Cubicin Outcomes Registry and Experience)显示文摘	Lübbert C Wilhelms D Worlitzsch D	2012	Z Gastroenterol2012，50，4：	1
2	Epigenetic targets in hematopoietic malignancies显示文摘	Claus R Lübbert M	2003	Oncogene2003，22，42：	1
3	Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-riskmyelodysplastic syndrome(MDS)ineligible for intensive chemotherapy:final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDSStudy Group显示文摘	Lübbert M Suciu S Baila L	2011	J Clin Oncol2011，29，15：	1
4	Normal regional right ventricular function and its change with age:a Doppler myocardial imaging study显示文摘	Kukulski T Hübbert L Arnold M		0，，：	1
5	Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk myelodysplastic syndrome(MDS) ineligible for intensive chemotherapy:final results of the randomized phase Ⅲ study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the GermanMDS Study Group显示文摘	Lübbert M Suciu S Baila L	2011	J Clin Oncol2011，29，15：	1
6	Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy:final results of the randomized phase Ⅲ study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group显示文摘	Lübbert M Suciu S Baila L	2011	J Clin Oncol2011，29，15：	1
7	An epigenetic approach to the treatment of advanced MDS,the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients显示文摘	Wijermans PW Lübbert M Verhoef G		0，，1：	1
8	The effects of 5-aza-2′-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes显示文摘	Joan van den Bosch Michael Lübbert Gregor Verhoef P.W Wijermans	2004	Leukemia Research2004，，8：	2
9	Efficacy of a 3-day,low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting显示文摘	Lübbert M Bertz H Wsch R		0，，：	1
10	DNA Methylation as a Therapeutic Target in Hematologic Disorders: Recent Results in Older Patients with Myelodysplasia and Acute Myeloid Leukemia显示文摘	Bj?rn Rüter Pierre W. Wijermans Michael Lübbert	2004	International Journal of Hematology2004，，2：	1
11	Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine(DAC)prior to allogeneic blood SCT of older MDS/AML patients显示文摘	Lübbert M Bertz H Rüter B	2009	Bone Marrow Transplant2009，44，：	1
12	A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy显示文摘	Lübbert M Rüter BH Claus R	2012	Haematologica2012，97，3：	1
13	A single center experience with the Heart MateⅡleft ventricular assist device(LVAD)显示文摘	Granfeldt H Peterzén B Hübbert L	2009	Scand Cardiovasc J2009，43，：	1
14	Epidemiology and resistance patterns of bacterial and fungal colonization of biliary plastic stents:aprospective cohort study显示文摘	Lübbert C Wendt K Feisthammel J	2016	PLoS One2016，11，01：	1
15	A multicenter phaseⅡtrial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy显示文摘	Lübbert M Rüter B H Claus R	2012	Haematologica2012，97，3：	1
16	Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methyhtion inhibitor 5-aza-2'-deoxycytidine显示文摘	Lübbert M Wijermans P Kunzmann R	2001	Br J Haematol2001，114，：	1
17	A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy显示文摘	Lübbert M Rüter BH Claus R		0，，03：	1
18	An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients显示文摘	P. W. Wijermans M. Lübbert G. Verhoef V. Klimek A. Bosly	2005	Annals of Hematology2005，，1：	1
19	An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients显示文摘	P. W. Wijermans M. Lübbert G. Verhoef V. Klimek A. Bosly	2005	Annals of Hematology2005，，：	1
20	CXCR4 is a prognostic marker in acute myelogenous leukemia显示文摘	Spoo AC Lübbert M Wierda WG	2007	Blood2007，109，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示